A Study of the Therapeutic Equivalency of MF DPI 100 mcg and 200 mcg Inhalers in Corticosteroid-Dependent Subjects With Moderate Asthma
Phase of Trial: Phase IV
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Mometasone (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Merck & Co; Merck Sharp & Dohme
- 24 Mar 2010 Actual number of patients (672) added as reported by ClinicalTrials.gov record.
- 24 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.